Pfizer Inc (PFE)

34.99
0.10 0.28
NYSE : Health Care
Prev Close 35.09
Open 35.23
Day Low/High 35.07 / 35.38
52 Wk Low/High 28.25 / 37.39
Volume 12.46M
Avg Volume 22.24M
Exchange NYSE
Shares Outstanding 6.07B
Market Cap 211.33B
EPS 1.10
P/E Ratio 15.69
Div & Yield 1.20 (3.40%)

Latest News

European Markets Mixed as Volatility Hits 17-Month Low

European Markets Mixed as Volatility Hits 17-Month Low

Mining stocks pull down London's benchmark index.

Stocks Slide as Crude Oil Extends Losses

Stocks Slide as Crude Oil Extends Losses

Stocks fall further into the red as a greater build to inventories accelerate losses in crude oil.

Pfizer's Latest Acquisition Could Add to Integration Risk

But we maintain the company is attractive to purchase for the secure, 3.4% dividend yield.

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer Is Buying a Portion of AstraZeneca's Antibiotics Business

Pfizer is making another acquisition.

Why Pfizer's Latest Deal Could Send Its Shares Soaring

Why Pfizer's Latest Deal Could Send Its Shares Soaring

The acquisition of Medivation gives the pharma giant a top-selling oncology drug and an immediate profit boost.

Stock Futures Little Changed in Wait for Friday's Yellen Speech

Stock Futures Little Changed in Wait for Friday's Yellen Speech

Stock futures remain close to the flatline on Wednesday as investors await a critical speech from Federal Reserve Chair Janet Yellen at the end of the week.

Earthquake in Central Italy Keeps Markets Cautious, Dozens Killed

Earthquake in Central Italy Keeps Markets Cautious, Dozens Killed

Pescara Del Tronto was one of the hardest hit towns in Central Italy as an earthquake rattled the country overnight.

Pfizer Picks Up AstraZeneca's Antibiotics Business

Pfizer Picks Up AstraZeneca's Antibiotics Business

The deal could be worth $1.5 billion.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

Pfizer buys antibiotics business from AstraZeneca; Tesla unveils Model S version that can go 300 miles on a single charge; U.S. stock futures rise slightly.

European Markets Steady; Italy Hit by Earthquake

European Markets Steady; Italy Hit by Earthquake

Central part of Italy hit by 6.2 magnitude earthquake.

Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca

Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca

Pfizer Inc. (NYSE:PFE) today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily...

Bristol-Myers Squibb And Pfizer To Present New Eliquis (apixaban) Analyses At ESC Congress 2016

Bristol-Myers Squibb And Pfizer To Present New Eliquis (apixaban) Analyses At ESC Congress 2016

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc.

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Earnings season is far from over, Cramer says, and the Fed chief gives a major speech Friday.

Market Keeps Chasing Its Own Tail

Stocks travel a good distance just to end up nowhere.

Stocks Waver as Investors Wait for Fed Clarity

Stocks Waver as Investors Wait for Fed Clarity

Wall Street will get more clues on the Fed's rate hike plans later this week, but uncertainty over what they might be led to jittery trading on Monday.

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks Struggle for Direction as Jackson Hole Conference Looms

Stocks fluctuate Monday afternoon as a selloff in crude oil hits the energy sector and Federal Reserve speeches at the end of the week leave investors wary.

Medivation Scores Premium in Sale to Pfizer

Medivation Scores Premium in Sale to Pfizer

Shareholders of the oncology drug maker ought to be satisfied with the auction's conclusion.

Cramer: A Bunch of Semis Are Ripe for the Picking

Cramer: A Bunch of Semis Are Ripe for the Picking

That's the hot spot in M&A right now.

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Shares of biotech micro-cap Cyclacel Pharmaceuticals have doubled in price in the past 10 days. Call it the Lloyd Christmas effect.

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back

Pfizer's $14 billion acquisition of Medivation is a strong purchase, according to Jim Cramer, who now wonders what Sanofi will do next.

Crude Selloff, Health Care Rally Split Wall Street

Crude Selloff, Health Care Rally Split Wall Street

Stocks fluctuate on Monday as doubts over a production freeze agreement from major oil-producing countries snapped crude oil's recent rally.

Pfizer to Pick Up Medivation in All-Cash Deal

PFE is trading up on the announcement, and the deal should add to earnings in 2017.

Pfizer Is Buying Medivation for $14 Billion

Pfizer Is Buying Medivation for $14 Billion

Pfizer confirmed its $14 billion acquisition of cancer drugmaker Medivation on Monday.

Stock Futures Slide as Crude's Winning Streak Is Snapped

Stock Futures Slide as Crude's Winning Streak Is Snapped

Stock futures move lower on Monday as doubts over a production freeze agreement from major oil-producing countries leave crude oil in the lurch.

Morning Movers: PFE, VRX, VIAB, FL, UA

Morning Movers: PFE, VRX, VIAB, FL, UA

Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

A potential blockbuster drug deal is reportedly in the works.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

Pfizer finalizes a deal to buy cancer drugmaker Medivation; ChemChina gets U.S. approval for its takeover of Syngenta; Viacom CEO Philippe Dauman is ousted.

Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation

Pfizer Confirms $14 Billion Takeover of Cancer Drugmaker Medivation

Acquiring Medivation will strengthen Pfizer's oncology franchise, which has lost ground in recent years to some Big Pharma competitors.